Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 38.60
+0.60 (1.58%)
Jul 15, 2026, 4:25 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 587.43 million as of July 15, 2026. Its market cap has decreased by -40.49% in one year.
Market Cap
587.43M
Enterprise Value
524.90M
Revenue
182.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.60
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 587.43M, an increase of 102.83%. That is a compound annual growth rate of 7.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 587.43M | -32.47% |
| Dec 30, 2025 | 869.82M | 43.88% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.15B |
| Nordhealth AS | 1.81B |
| Circio Holding ASA | 1.75B |
| Photocure ASA | 1.57B |
| Vistin Pharma ASA | 913.50M |
| Nykode Therapeutics AS | 904.53M |
| INIFY Laboratories AB | 849.05M |
| Lytix Biopharma ASA | 767.46M |